Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Tokarska-Schlattner 2007 Biochim Biophys Acta"

From Bioblast
Line 1: Line 1:
{{Publication
{{Publication
|title=Tokarska-Schlattner M, Dolder M, Gerber I, Speer O, Wallimann T, Schlattner U (2007) Reduced creatine-stimulated respiration in doxorubicin challenged mitochondria: particular sensitivity of the heart. Biochim Biophys Acta 1767: 1276-1284.
|title=Tokarska-Schlattner M, Dolder M, Gerber I, Speer O, Wallimann T, Schlattner U (2007) Reduced creatine-stimulated respiration in doxorubicin challenged mitochondria: Particular sensitivity of the heart. Biochim Biophys Acta 1767: 1276-1284.
|info=[http://www.ncbi.nlm.nih.gov/pubmed/17935690 PMID: 17935690]
|info=[http://www.ncbi.nlm.nih.gov/pubmed/17935690 PMID: 17935690]
|authors=Tokarska-Schlattner M, Dolder M, Gerber I, Speer O, Wallimann T, Schlattner U
|authors=Tokarska-Schlattner M, Dolder M, Gerber I, Speer O, Wallimann T, Schlattner U
Line 11: Line 11:
}}
}}
{{Labeling
{{Labeling
|instruments=Oxygraph-2k
|area=Respiration, Comparative MiP; environmental MiP
|injuries=Mitochondrial Disease; Degenerative Disease and Defect
|organism=Human
|organism=Human
|tissues=Heart, Nervous system
|tissues=Heart, Nervous system
|preparations=Isolated Mitochondria, Enzyme
|preparations=Isolated Mitochondria, Enzyme
|injuries=Mitochondrial Disease; Degenerative Disease and Defect
|topics=ADP, Inhibitor, PCr,Cr
|couplingstates=OXPHOS
|couplingstates=OXPHOS
|kinetics=ADP; Pi, Inhibitor; Uncoupler
|instruments=Oxygraph-2k
|additional=Pharmacology; Biotechnology
|additional=Pharmacology; Biotechnology
|discipline=Biomedicine, Pharmacology; Biotechnology
|discipline=Biomedicine, Pharmacology; Biotechnology
}}
}}

Revision as of 13:39, 11 August 2013

Publications in the MiPMap
Tokarska-Schlattner M, Dolder M, Gerber I, Speer O, Wallimann T, Schlattner U (2007) Reduced creatine-stimulated respiration in doxorubicin challenged mitochondria: Particular sensitivity of the heart. Biochim Biophys Acta 1767: 1276-1284.

Β» PMID: 17935690

Tokarska-Schlattner M, Dolder M, Gerber I, Speer O, Wallimann T, Schlattner U (2007) Biochim Biophys Acta

Abstract: Doxorubicin (DXR) belongs to the most efficient anticancer drugs. However, its use is limited by a risk of cardiotoxicity, which is not completely understood. Recently, we have shown that DXR impairs essential properties of purified mitochondrial creatine kinase (MtCK), with cardiac isoenzyme (sMtCK) being particularly sensitive. In this study we assessed the effects of DXR on respiration of isolated structurally and functionally intact heart mitochondria, containing sMtCK, in the presence and absence of externally added creatine (Cr), and compared these effects with the response of brain mitochondria expressing uMtCK, the ubiquitous, non-muscle MtCK isoenzyme. DXR impaired respiration of isolated heart mitochondria already after short-term exposure (minutes), affecting both ADP- and Cr-stimulated respiration. During a first short time span (minutes to 1 h), detachment of MtCK from membranes occurred, while a decrease of MtCK activity related to oxidative damage was only observed after longer exposure (several hours). The early inhibition of Cr-stimulated respiration, in addition to impairment of components of the respiratory chain involves a partial disturbance of functional coupling between MtCK and ANT, likely due to interaction of DXR with cardiolipin leading to competitive inhibition of MtCK/membrane binding. The relevance of these findings for the regulation of mitochondrial energy production in the heart, as well as the obvious differences of DXR action in the heart as compared to brain tissue, is discussed. β€’ Keywords: Anthracycline, Creatine kinase, Cardiotoxicity, Isolated mitochondria, Creatine-simulated respiration

β€’ O2k-Network Lab: CH_Zurich_Wallimann T


Labels: MiParea: Respiration, Comparative MiP; environmental MiP"Comparative MiP; environmental MiP" is not in the list (Respiration, Instruments;methods, mt-Biogenesis;mt-density, mt-Structure;fission;fusion, mt-Membrane, mtDNA;mt-genetics, nDNA;cell genetics, Genetic knockout;overexpression, Comparative MiP;environmental MiP, Gender, ...) of allowed values for the "MiP area" property. 

Stress:Mitochondrial Disease; Degenerative Disease and Defect"Mitochondrial Disease; Degenerative Disease and Defect" is not in the list (Cell death, Cryopreservation, Ischemia-reperfusion, Permeability transition, Oxidative stress;RONS, Temperature, Hypoxia, Mitochondrial disease) of allowed values for the "Stress" property.  Organism: Human  Tissue;cell: Heart, Nervous system  Preparation: Isolated Mitochondria"Isolated Mitochondria" is not in the list (Intact organism, Intact organ, Permeabilized cells, Permeabilized tissue, Homogenate, Isolated mitochondria, SMP, Chloroplasts, Enzyme, Oxidase;biochemical oxidation, ...) of allowed values for the "Preparation" property., Enzyme 

Regulation: ADP, Inhibitor, PCr"PCr" is not in the list (Aerobic glycolysis, ADP, ATP, ATP production, AMP, Calcium, Coupling efficiency;uncoupling, Cyt c, Flux control, Inhibitor, ...) of allowed values for the "Respiration and regulation" property., Cr"Cr" is not in the list (Aerobic glycolysis, ADP, ATP, ATP production, AMP, Calcium, Coupling efficiency;uncoupling, Cyt c, Flux control, Inhibitor, ...) of allowed values for the "Respiration and regulation" property.  Coupling state: OXPHOS 

HRR: Oxygraph-2k 

Pharmacology; Biotechnology